Table 1.
Project | Reconstruction group (n=58) | control group (n=50) | p value |
---|---|---|---|
Age (year) | (73.7 ± 7.3) | (71.6 ± 5.4) | P=0.288 |
Prostate volume (cc) | (40.9 ± 5.8) | (39.8 ± 3.1) | P=0.390 |
Prostate specific antigen(PSA) (ng/mL) | (11.7 ± 2.4) | (13.2 ± 3.5) | P=0.165 |
Body Mass Index(BMI: kg/m2) | (24.2 ± 4.2) | (26.3 ± 3.2) | P=0.230 |
preoperative Gleason score n(%) | P=0.132 | ||
6 points | 13(22.4) | 10(20) | |
7 points | 45(77.6) | 40(80) | |
clinical stage n(%) | P=0.249 | ||
T1c | 17(29.3) | 13(26) | |
T2a∼T2b | 35(60.3) | 33(66) | |
T2c | 6(10.4) | 4(8) |